ADMA Biologics
ADMA
$6.81
Share price
1.04%
Change (1 day)
99.12%
Change (1 year)
Categories
ADMA Biologics (ADMA) - Net assets
Net assets on the balance sheet as of December 2023 : $0.13 B
According to ADMA Biologics
's latest financial reports the company has $0.13 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
ADMA Biologics - Net assets on balance sheet (from 2010 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.13 B | -11.03% |
| 2022-12-31 | $0.15 B | 7.65% |
| 2021-12-31 | $0.14 B | 59.97% |
| 2020-12-31 | $88.24 M | 236.92% |
| 2019-12-31 | $26.19 M | 32.49% |
| 2018-12-31 | $19.77 M | -50.98% |
| 2017-12-31 | $40.33 M | -1004.88% |
| 2016-12-31 | $-4.46 M | -642.92% |
| 2015-12-31 | $0.82 M | -86.34% |
| 2014-12-31 | $6 M | -72.15% |
| 2013-12-31 | $21.57 M | 128.93% |
| 2012-12-31 | $9.42 M | |
| 2011-06-30 | $-0.01 M | 277.46% |
| 2010-06-30 | $-0.01 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | $1.97 B | 1,357.92% | 🇺🇸 USA |
 Novavax NVAX | -$0.72 B | -630.25% | 🇺🇸 USA |
 Cel-Sci
CVM | $12.65 M | -90.64% | 🇺🇸 USA |